Recent Updates
Recently added Catalysts

Davion Healthcare Plc

DAVIFDA catalysts, PDUFA dates & pipeline intelligence
$6
▼ -5.65 · -48.5%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full DAVI financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
Volume
479.47 K
Value Traded
-
Short % Float
-

Cash Data

Unlock DAVI cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
-
EPS (TTM)
-
P/E Ratio
-
Ent. Value
-
Total Shares
-
Float Shares
-
Insiders
-
Institutions
-

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
PDUFA
2026
Example Drug
Treatment for example condition requiring FDA review
Phase 3Small MoleculeOncology-
Unlock every DAVI catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

DAVI Catalyst Timeline

Dated clinical, regulatory and corporate events for Davion Healthcare Plc

Unlock the full DAVI catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How DAVI actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
-Example Drug Phase 3 data readout Phase 3
Unlock all DAVI historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Davion Healthcare Plc is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every DAVI program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Example Drug Example indication for clinical evaluationPhase 32025-12-01The study met its primary endpoint demonstrating statistically significant improvement.Read MorePhase 3 Study Results AnnouncementRead More
Scroll for more · summaries link to the source press release
Unlock every DAVI trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock DAVI insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
John SmithCEOBuy 50,000 150,000 held$45.50 01/10/2026
Unlock the full DAVI insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Hedge Funds invested in DAVI

Fund % of Portfolio Current MV Shares Owned Activity
No hedge fund reported a 13F position in DAVI for Q2 2026.
Unlock every fund holding DAVI
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in DAVI
Shares held by hedge funds each quarter, and who bought or sold.

DAVI Institutional Ownership Trends

Options Data

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock DAVI option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live DAVI option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock DAVI options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How DAVI ranks across every disease it competes in

Competitive Position is a premium feature
See how DAVI ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

DAVI News

-DAVI
Oct 26, 2026
DAVIGeneral
▼ -48.5%today

Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP

Davion Healthcare has acquired the intellectual property of WoundSkan and Spektra for $25 million. The deal includes cash and shares, enhancing Davion's portfolio in health monitoring technologies. WoundSkan offers smart wound monitoring, while Spektra provides rapid screening for various conditions. This acquisition aligns with Davion's growth strategy following its recent Nasdaq listing.

Read more →

About Davion Healthcare Plc

BIOPHARMAWATCH ELITE PLUS
Trade the next DAVI catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime